Related Experiment Video
Updated: Mar 13, 2026
08:44
Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
1.4K
Ventilatory limitation and dynamic hyperinflation during exercise testing in Cystic Fibrosis
Solon Karapanagiotis1, Simone Gambazza1, Anna Brivio1
1Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Cystic Fibrosis Centre, University of Milan, Milan, Italy.
Pediatric Pulmonology
|October 14, 2016
Summary
Dynamic hyperinflation is common in Cystic Fibrosis (CF) patients after the Modified Shuttle Test (MST). This condition was not linked to standard ventilatory limitation measures during exercise in the study.
Area of Science:
- Pulmonary Medicine
- Exercise Physiology
- Cystic Fibrosis Research
Background:
- Cystic Fibrosis (CF) is a genetic disorder affecting lung function.
- Dynamic hyperinflation can impair exercise tolerance in respiratory diseases.
- The Modified Shuttle Test (MST) is used to assess exercise capacity in CF.
Purpose of the Study:
- To determine the prevalence of dynamic hyperinflation post-MST in CF patients.
- To explore the relationship between dynamic hyperinflation and lung function, exercise tolerance, and symptoms in CF.
- To identify factors associated with dynamic hyperinflation during exercise in CF.
Main Methods:
- Retrospective observational study design.
- Inclusion of clinically stable CF patients with confirmed diagnosis.
- Analysis of MST, spirometry, maximal voluntary ventilation, and inspiratory capacity data.
Main Results:
- Dynamic hyperinflation was observed in 22 subjects during the MST.
- Thirteen subjects experienced ventilatory limitation during exercise.
- No significant association was found between dynamic hyperinflation and traditional ventilatory limitation parameters.
Conclusions:
- Dynamic hyperinflation is a frequent finding in CF patients undergoing the MST.
- Dynamic hyperinflation during the MST is not associated with standard ventilatory limitation parameters.
- Further research may be needed to understand the clinical implications of dynamic hyperinflation in CF.
Keywords:
cystic fibrosisdynamic hyperinflationexercise tolerancemodified shuttle testrespiratory function testsMore Related Videos
07:09Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
Published on: February 20, 2017
13.8K
09:33Using Near-Infrared Spectroscopy Wearable Devices to Identify Central Versus Peripheral Limitations During Exercise
Published on: December 19, 2024
1.7K
Related Concept Videos
01:30Acute Respiratory Failure-III
1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
01:17Pulmonary Cycle: Exhalation
4.5K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.5K
01:25Hyperpnea and Hyperventilation
3.5K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
3.5K
01:19Factors Affecting Pulmonary Ventilation
3.6K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
3.6K
01:23Mechanical Ventilation II: Invasive Ventilation
941
Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
941
01:24Cystic Fibrosis: Management
601
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
601